This page includes the latest FDA filings for Arch Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | OTHER OTC Market | ARTH | DUNS 781725705 |
Device Company | Device | Date |
|---|---|---|
Arch Therapeutics, Inc. | AC5 Topical Gel | 2020-03-11 |
Arch Therapeutics, Inc. | AC5 Topical Gel | 2018-12-14 |
| NCAGE Code | 4LGA3 | ARCH THERAPEUTICS, INC. |
| CAGE Code | 4LGA3 | ARCH THERAPEUTICS, INC. |
| S.A.M. Registration | 4LGA3 [781725705] | ARCH THERAPEUTICS, INC. |
| SEC | 0001537561 | Arch Therapeutics, Inc. of NEVADA |
| SEC | 0001502523 | Arch Therapeutics, Inc. of MASSACHUSETTS |
| SEC | 1537561 | Arch Therapeutics, Inc. of NEVADA |